Samuel G Katz

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 01, 2026
MET expression by immunohistochemistry as a biomarker in pancreatic neuroendocrine tumours.

|Feb 13, 2026
Ex Vivo Expansion of Melanoma Tumor-Infiltrating Lymphocytes Leads to a Dominant Exhausted T-cell Population with a Lack of Memory Markers.

Gianfilippo Coppola, Samuel Kerr, Pei-Chun Cha

|Feb 09, 2026
Nanobody MET CAR-T cells show efficacy in solid tumors.

Po-Han Chen, Qin Li, Sam Deveraux

|Jun 29, 2025
Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study.

Savanah D Gisriel, Ji Yuan, Haiming Tang

|Oct 09, 2024
Tumor-Specific Antigen Delivery for T-cell Therapy via a pH-Sensitive Peptide Conjugate.

Annali M Yurkevicz, Yanfeng Liu, Samuel G Katz

|Oct 20, 2021
Balancing life and death: BCL-2 family members at diverse ER-mitochondrial contact sites.

Robert E Means, Samuel G Katz

Pageof 1

Frequent Collaborators

2 joint publications

Pei-Chun Cha

1 joint publications

Annali M Yurkevicz

1 joint publications

Yanfeng Liu

1 joint publications

Peter M Glazer